RATED A+ | NEW
Ototoxic Drugs
Vancomycin (an bio cs), aminoglycosides, loop diure cs, cispla n
Also: NSAIDs, acetaminophen, quinine, chemo drugs (ex. cispla n), an malarials
hepatoxic drugs
Acetaminophen (most common)
an -fungals
Nephrotoxic drugs
aminoglycosides. amphotericin B. ACE inhibitors. cicpla n. cyclosporin. NSAIDS. Radiographic I
V contrasts.
Vancomycin
Glaucoma meds: Prostaglandin agonists (end in -prost)
lowers IOP by allowing more ou,low of aqueous humor
Glaucoma meds: Adrenergic Agonists (apraclonidine, brimonidine tartrate, dipivefrin
hydrochloride)
reduces amount of aqueous humor produced by ciliary bodies, lowering IOP
Glaucoma meds: Beta-Adrenergic Blockers (betaxolol hydrochloride, carteolol, levobunolol,
molol)
decreased IOP by blocking beta-adrenergic receptors so less aqueous humor is produced
Glaucoma meds: cholinergic agonists (pilocarpine, echothiophate, carbachol)
lower IOP by decreasing amount of aqueous humor produced
Glaucoma meds: carbonic anhydrase inhibitors (brinzolamide, dorzolamide)
reduce IOP by inhibi ng produc on of aqueous humor
What's important to monitor for glaucoma pa ents when on meds?
monitor I&O
, Emphysema Acronym
PINK Puffer
Pink skin, pursed lip breathing
Increased chest (barrel chest)
No chronic cough (minimal)
Keep tripoding
Chronic Bronchi s Acronym
BLUE Bloater
Blue color (cyanosis)
Long chronic cough
Unusual breath sounds (wheezing and crackles)
Edema
Low Oxygen s/s (hypoxia)
restlessness, agita on, decreased LOC
Celiac disease
- no gluten
- give fat soluble vitamins (ADEK)
- S/S: abdominal pain, steatorrhea, diarrhea, (stunted growth and slowed puberty in children)
wt. loss
Chron's disease
- auto-immune (exacerba ons and remissions)
- causes: Stress, Smoking, Sepsis (infec on)
- can include all GI tract
- "skip lesions"- don't bleed
- granulomas (bumps and lumps in bowel wall)
- s/s: 5 loose stools/day (mucus/pus) and steatorrhea
Ulceri ve Coli s
chronic inflammatory disease of the colon
- s/s: 15-20 bloody stools/day
- decreased H/H (anemia)
- Rebound tenderness- REPORT